Lance Alstodt
2021
In 2021, Lance Alstodt earned a total compensation of $21.3M as Chief Executive Officer at BioRestorative Therapies, a 33,082% increase compared to previous year.
Compensation breakdown
| Option Awards | $14,081,677 |
|---|---|
| Salary | $275,000 |
| Stock Awards | $6,984,812 |
| Total | $21,341,489 |
Alstodt received $14.1M in option awards, accounting for 66% of the total pay in 2021.
Alstodt also received $275K in salary and $7M in stock awards.
Rankings
In 2021, Lance Alstodt's compensation ranked 287th out of 12,415 executives tracked by ExecPay. In other words, Alstodt earned more than 97.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 287 out of 12,415 | 98th |
Division Services | 109 out of 2,290 | 95th |
Major group Health Services | 11 out of 252 | 96th |
Industry group Miscellaneous Health And Allied Services, Not | 1 out of 32 | 97th |
Source: SEC filing on September 23, 2022.
Alstodt's colleagues
We found two more compensation records of executives who worked with Lance Alstodt at BioRestorative Therapies in 2021.